Browsing by Author "Malek Touabi"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • No Thumbnail Available
    PublicationMetadata only
    Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria
    (2009-12-01) Elizabeth A. Ashley; Malek Touabi; Margareta Ahrer; Robert Hutagalung; Khayae Htun; Jennifer Luchavez; Christine Dureza; Stephane Proux; Mara Leimanis; Myo Min Lwin; Alena Koscalova; Eric Comte; Prudence Hamade; Anne Laure Page; François Nosten; Philippe J. Guerin; Epicentre; Imperial College Healthcare NHS Trust; Médecins Sans Frontières-Switzerland; Gokila; Shoklo Malaria Research Unit; Mahidol University; Nuffield Department of Clinical Medicine; Medecins Sans Frontieres; Médecins Sans Frontières Malaria Working Group; Malaria Consortium
    Background. In areas where non-falciparum malaria is common rapid diagnostic tests (RDTs) capable of distinguishing malaria species reliably are needed. Such tests are often based on the detection of parasite lactate dehydrogenase (pLDH). Methods. In Dawei, southern Myanmar, three pLDH based RDTs (CareStart Malaria pLDH (Pan), CareStart Malaria pLDH (Pan, Pf) and OptiMAL-IT®)were evaluated in patients presenting with clinically suspected malaria. Each RDT was read independently by two readers. A subset of patients with microscopically confirmed malaria had their RDTs repeated on days 2, 7 and then weekly until negative. At the end of the study, samples of study batches were sent for heat stability testing. Results. Between August and November 2007, 1004 patients aged between 1 and 93 years were enrolled in the study. Slide microscopy (the reference standard) diagnosed 213 Plasmodium vivax (Pv) monoinfections, 98 Plasmodium falciparum (Pf) mono-infections and no malaria in 650 cases. The sensitivities (sens) and specificities (spec), of the RDTs for the detection of malaria were- CareStart MalariaTMpLDH (Pan) test: sens 89.1% [CI9584.2-92.6], spec 97.6% [CI9596.5-98.4]. OptiMal-IT®: Pf+/- other species detection: sens 95.2% [CI9587.5-98.2], spec 94.7% [CI9593.3-95.8]; non-Pf detection alone: sens 89.6% [CI9583.6-93.6], spec 96.5% [CI9594.8-97.7]. CareStart Malaria pLDH (Pan, Pf): Pf+/- other species: sens 93.5% [CI9585.4-97.3], spec 97.4% [95.9-98.3]; non-Pf: sens 78.5% [CI9571.1-84.4], spec 97.8% [CI9596.3-98.7]. Inter-observer agreement was excellent for all tests (kappa > 0.9). The median time for the RDTs to become negative was two days for the CareStart Malaria tests and seven days for OptiMAL-IT®. Tests were heat stable up to 90 days except for OptiMAL-IT®(Pf specific pLDH stable to day 20 at 35°C). Conclusion. None of the pLDH-based RDTs evaluated was able to detect non-falciparum malaria with high sensitivity, particularly at low parasitaemias. OptiMAL-IT®performed best overall and would perform best in an area of high malaria prevalence among screened fever cases. However, heat stability was unacceptable and the number of steps to perform this test is a significant drawback in the field. A reliable, heat-stable, highly sensitive RDT, capable of diagnosing all Plasmodium species has yet to be identified. © 2009 Ashley et al; licensee BioMed Central Ltd.